Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cobalis Corporation
Cobalis Corporation and International Shipping and Marketing LLC Announce Signed Letter of Intent for Distribution and Marketing of Flagship Anti-Allergy Product PreHistin®
June 20th, 2009
Cobalis Corporation (OTC:CLSC), a pharmaceutical and nutraceutical biotechnology company specializing in the development of anti-allergy medications announced that they have completed a signed Letter of Intent (LOI) with International Shipping and Marketing LLC (ISM) to distribute and market PreHistin®. PreHistin® is Cobalis’ patented revolutionary allergy prevention product available for worldwide sales at www.PreHistin.com. ISM, located in Newark, New Jersey will immediately begin order fulfillment for Cobalis’ PreHistin® domestic and international sales while also agreeing to begin wholesale distribution and marketing for PreHistin® sales in the Eastern United...
Source: Law & Health Weekly (2009-06-20)
|
